GERN
Geron Corp
Price:  
4.52 
USD
Volume:  
5,323,912.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN EV/EBITDA

-232.0%
Upside

As of 2024-09-19, the EV/EBITDA ratio of Geron Corp (GERN) is -11.86. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GERN's latest enterprise value is 2,691.15 mil USD. GERN's TTM EBITDA according to its financial statements is -226.96 mil USD. Dividing these 2 quantities gives us the above GERN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 9.2x - 17.8x 13.8x
Forward P/E multiples 14.8x - 22.7x 18.2x
Fair Price (5.53) - (6.65) (5.97)
Upside -222.4% - -247.0% -232.0%
4.52 USD
Stock Price
(5.97) USD
Fair Price

GERN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-09-18 -11.86
2024-09-17 -11.94
2024-09-16 -11.46
2024-09-13 -11.83
2024-09-12 -11.67
2024-09-11 -11.51
2024-09-10 -11.38
2024-09-09 -11.57
2024-09-06 -11.14
2024-09-05 -11.22
2024-09-04 -11.25
2024-09-03 -11.54
2024-08-30 -12.47
2024-08-29 -11.96
2024-08-28 -11.83
2024-08-27 -12.23
2024-08-26 -11.96
2024-08-23 -11.91
2024-08-22 -11.75
2024-08-21 -11.91
2024-08-20 -12.12
2024-08-19 -11.70
2024-08-16 -11.80
2024-08-15 -11.70
2024-08-14 -11.65
2024-08-13 -11.99
2024-08-12 -12.42
2024-08-09 -12.34
2024-08-08 -12.07
2024-08-07 -11.96
2024-08-06 -12.07
2024-08-05 -11.83
2024-08-02 -11.99
2024-08-01 -12.55
2024-07-31 -12.44
2024-07-30 -12.31
2024-07-29 -12.31
2024-07-26 -12.23
2024-07-25 -11.25
2024-07-24 -11.25
2024-07-23 -12.12
2024-07-22 -12.28
2024-07-19 -12.07
2024-07-18 -12.26
2024-07-17 -12.50
2024-07-16 -13.11
2024-07-15 -12.87
2024-07-12 -12.36
2024-07-11 -12.50
2024-07-10 -12.07